Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Empirical Antimicrobial Therapy vs Early Open Lung Biopsy/Specific Therapy for Diffuse Interstitial Pneumonitis in Immunocompromised Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				no age specified								NCI-82-C-111


2.		Phase III Management and Prophylaxis of Fever and Infection with Antimicrobial Treatment in Cancer Patients (Study III)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				no age specified								NCI-81-C-189 NCI-POB-8103


3.		Phase III Prospective Randomized Study of Empiric Antibiotic Therapy with Ceftazidime/Amikacin/Vancomycin vs Ceftazidime/Amikacin in Febrile Granulocytopenic Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				any age								EORTC-46852


4.		Phase III Randomized Study of Initial Empiric Antimicrobial Therapy with TMP-SMX/Erythromycin and Other Antibiotics as Indicated vs Pretreatment Bronchoalveolar Lavage and Pathogen-Specific Therapy in Immunocompromised Patients with Diffuse Interstitial Pneumonitis (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				no age specified				NCI				NCI-86-C-26 NCI-T86-0081N, T86-0081

Last Modified: 6/1/1997


5.		Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				any age				NCI				NCI-85-C-212C NCI-T86-0036N, T86-0036

Last Modified: 11/1/1987


6.		Randomized Prospective Trial of Ceftazidime with and without Vancomycin in the Management of Febrile Granulocytopenic Patients (Summary Last Modified 11/87)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Completed				18 and over				NCI				NCI-86-C-227 NCI-NMOB-863, NCI-T87-0022N, T87-0022

Last Modified: 7/1/1989


7.		Prospective, Randomized Study of Single Daily Dose of Ceftriaxone/Amikacin vs Multiple Daily Dose of Ceftazidime/Amikacin as Empirical Therapy for Fever in Cancer Patients with Granulocytopenia (Summary Last Modified 07/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				any age								EORTC-46882

Last Modified: 12/1/1997


8.		Antimicrobial Management of Fever and Neutropenia in Cancer Patients --- Fever Study V Short Arm, A Multicenter Study

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Completed				5 and over				NCI				NCI-92-C-0085L NCI-T92-0043N, T92-0043

Last Modified: 9/1/1993


9.		Randomized Study of Meropenem vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Cancer Patients with Granulocytopenia (Summary Last Modified 09/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				at least 3 months								EORTC-46931

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute